Giuseppe Derosa Selected Research

Sitagliptin Phosphate (Januvia)

10/2019	Effects of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus After 7 Years of Therapy.
10/2015	Sitagliptin in type 2 diabetes mellitus: Efficacy after five years of therapy.
4/2014	Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2-year study evaluation.
3/2013	A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study.
1/2013	Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metformin.
12/2012	A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function.
10/2012	Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients.
6/2010	Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Derosa Research Topics

Disease

69	Insulin Resistance 10/2022 - 08/2004
69	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2002
42	Body Weight (Weight, Body) 05/2021 - 04/2003
30	Hypertension (High Blood Pressure) 03/2021 - 02/2003
21	Inflammation (Inflammations) 01/2021 - 04/2006
18	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015 - 05/2004
13	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 10/2004
11	Hypercholesterolemia 11/2020 - 04/2003
10	Essential Hypertension 02/2017 - 07/2003
9	Overweight 05/2016 - 08/2007
8	Obesity 01/2018 - 08/2004
8	Atherosclerosis 01/2018 - 04/2009
7	Hyperlipidemias (Hyperlipidemia) 01/2022 - 10/2004
7	Glucose Intolerance 09/2020 - 01/2006
6	Atrial Fibrillation 01/2023 - 03/2008
6	COVID-19 01/2022 - 01/2021
6	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 06/2010
5	Coronary Disease (Coronary Heart Disease) 11/2020 - 02/2003
5	Dyslipidemias (Dyslipidemia) 11/2020 - 04/2009
5	Weight Loss (Weight Reduction) 01/2017 - 05/2008
5	Acute Coronary Syndrome 01/2017 - 01/2007
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2015 - 04/2009
4	Diabetes Mellitus 05/2021 - 07/2003
4	Neoplasms (Cancer) 01/2018 - 01/2016
3	Infections 01/2022 - 01/2017
3	Fibrosis (Cirrhosis) 10/2020 - 03/2012
3	Heart Failure 01/2019 - 10/2010

Drug/Important Bio-Agent (IBA)

53	LipidsIBA 01/2023 - 04/2003
50	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 07/2003
43	Insulin (Novolin)FDA Link 03/2022 - 08/2004
29	Metformin (Glucophage)FDA LinkGeneric 05/2021 - 06/2003
26	C-Reactive ProteinIBA 01/2023 - 04/2006
23	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 08/2004
21	Amlodipine (Norvasc)FDA LinkGeneric 07/2015 - 12/2002
17	oxidized low density lipoproteinIBA 01/2023 - 04/2003
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2006
17	Pioglitazone (Actos)FDA Link 01/2018 - 05/2004
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2009
16	ResistinIBA 01/2021 - 05/2008
15	Rosiglitazone (Avandia)FDA Link 01/2018 - 05/2004
13	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022 - 05/2005
13	AdiponectinIBA 01/2020 - 05/2008
12	CholesterolIBA 11/2020 - 04/2003
12	HDL CholesterolIBA 11/2020 - 04/2003
11	Triglycerides (Triacylglycerol)IBA 01/2021 - 04/2003
11	LDL CholesterolIBA 11/2020 - 04/2003
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 10/2004
10	Nicotinamide PhosphoribosyltransferaseIBA 01/2021 - 01/2010
10	olmesartanIBA 01/2014 - 01/2008
9	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2005
9	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018 - 09/2007
9	Acarbose FDA LinkGeneric 01/2017 - 01/2006
9	Vitamin A (Retinol)FDA LinkGeneric 05/2015 - 01/2010
9	glimepiride (Amarel)FDA LinkGeneric 07/2014 - 02/2003
9	Telmisartan (Micardis)FDA Link 06/2012 - 07/2004
9	Antihypertensive Agents (Antihypertensives)IBA 01/2011 - 07/2003
8	Sitagliptin Phosphate (Januvia)FDA Link 10/2019 - 06/2010
8	Valsartan (Vals)FDA Link 01/2012 - 03/2005
7	Glucagon (Glukagon)FDA Link 07/2014 - 06/2012
7	LeptinIBA 10/2011 - 03/2005
6	Lipoprotein(a)IBA 03/2022 - 02/2003
6	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2006
6	sibutramine (Meridia)FDA Link 01/2017 - 11/2008
6	VildagliptinIBA 01/2017 - 06/2012
6	Carnitine (L-Carnitine)FDA LinkGeneric 05/2015 - 05/2003
6	ProinsulinIBA 07/2014 - 06/2010
6	Ramipril (Altace)FDA LinkGeneric 12/2013 - 09/2008
6	ThiazolidinedionesIBA 06/2012 - 02/2008
6	Irbesartan FDA LinkGeneric 12/2011 - 06/2005
5	CurcuminIBA 10/2022 - 01/2016
5	QuercetinIBA 01/2022 - 01/2021
5	AdipokinesIBA 01/2021 - 12/2012
5	CanrenoneIBA 01/2019 - 11/2013
5	Metalloproteases (Metalloproteinases)IBA 02/2015 - 01/2007
5	Orlistat (Xenical)FDA Link 05/2012 - 04/2003
5	candesartanIBA 12/2011 - 07/2003
5	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2011 - 01/2004
4	PolyphenolsIBA 01/2022 - 12/2017
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
4	Plasminogen Activator Inhibitor 1IBA 01/2021 - 05/2005
4	AldosteroneIBA 01/2018 - 03/2010
4	red yeast riceIBA 01/2017 - 08/2013
4	BerberineIBA 01/2017 - 01/2012
4	Losartan (Cozaar)FDA LinkGeneric 04/2016 - 04/2009
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2015 - 07/2003
4	C-PeptideIBA 08/2013 - 06/2012
4	Arginine (L-Arginine)FDA Link 08/2013 - 06/2012
3	Thrombin FDA Link 01/2023 - 01/2021
3	Fibrinogen (Factor I)FDA Link 01/2023 - 01/2008
3	CreatinineIBA 01/2023 - 06/2009
3	Therapeutic UsesIBA 01/2022 - 01/2016
3	AntioxidantsIBA 01/2022 - 01/2011
3	ertugliflozinIBA 05/2021 - 01/2017
3	HomocysteineIBA 01/2021 - 02/2003
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2021 - 02/2003
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 04/2009
3	Angiotensin Receptor AntagonistsIBA 01/2018 - 04/2007

Therapy/Procedure

51	Therapeutics 01/2022 - 05/2003
36	Glycemic Control 01/2018 - 02/2003
3	Drug Therapy (Chemotherapy) 11/2020 - 06/2003